Endoparasites
Hc (Haemonchus contortus) / sensitive / resistant
Tc (Trichostrongylus colubriformis) / sensitive / resistant
Treatment exposure modality: | Immersion for 144h |
Efficacy type: | Motility reduction (%) |
Stock solution: | 20 mM in DMSO |
Compound quantity | < 2 mg |
Positive control | Ivermectin |
In Brief:
The Invenesis GI larval devlopment assay measures the effect of
compounds on the motility of freshly developed L3 larvae.
Eggs of a gastrointestinal nematode are deposited in a
multi-well plate together with food (E. coli) and the treatment formulated in
DMSO. Plates are incubated for up to 6 days to allow the development of
nematodes up to the L3-stage. The effect of compounds is measured as motility
reduction using an automated data acquisition system. Efficacy is expressed in %
motility reduction compared to negative controls.
Definitions:
To ensure flawless communication, the following definition section introduces the vocabulary used at INVENesis. You will find this vocabulary on our quotes, raw data files, processed data files, preliminary and final reports. Open the Lexicon below.